
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. (GLUE)
WebsitePrice
Market cap
Next catalystQ4 2026; proposed trial design subject to FDA reviewMRT-8102 — GEMINI-1 · Trial initiationCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P3FilingApproved